<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created by RR Donnelley IM Processor 4.0.0.0 using Fujitsu Interstage XWand-->
<xbrl xmlns:cvst1="http://www.jackson.com/20120910" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:rr="http://xbrl.sec.gov/rr/2012-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="cvst1-20120910.xsd" />
  <context id="Duration_01May2011_30Apr2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035573_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035573Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035568_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035568Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035569_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035569Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035570_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035570Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035571_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035571Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035572_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035572Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035587_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035587Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035588_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035588Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035589_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035589Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035591_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035591Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035592_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035592Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035593_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035593Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000037897_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000037897Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000037900_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000037900Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035576_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035576Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035574_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035574Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035579_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035579Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035581_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035581Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000037899_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000037899Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035586_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035586Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000035590_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000035590Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <context id="Duration_01May2011_30Apr2012S000037896_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001532747</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvst1:S000037896Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-05-01</startDate>
      <endDate>2012-04-30</endDate>
    </period>
  </context>
  <dei:EntityRegistrantName contextRef="Duration_01May2011_30Apr2012">CURIAN VARIABLE SERIES TRUST</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="Duration_01May2011_30Apr2012">Other</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="Duration_01May2011_30Apr2012">2011-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="Duration_01May2011_30Apr2012">0001532747</dei:EntityCentralIndexKey>
  <dei:AmendmentFlag contextRef="Duration_01May2011_30Apr2012">false</dei:AmendmentFlag>
  <dei:DocumentCreationDate contextRef="Duration_01May2011_30Apr2012">2012-09-10</dei:DocumentCreationDate>
  <rr:ProspectusDate contextRef="Duration_01May2011_30Apr2012">2012-04-30</rr:ProspectusDate>
  <dei:DocumentEffectiveDate contextRef="Duration_01May2011_30Apr2012">2012-09-10</dei:DocumentEffectiveDate>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035573_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035568_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035569_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035570_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035571_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035572_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035587_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035588_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035589_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035591_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035592_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035593_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000037897_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000037900_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035576_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035574_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035579_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035581_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000037899_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt;&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Principal Risks of Investing in the Fund&lt;/font&gt;&amp;#8221; please add the following risks:&lt;/font&gt;&lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;China and India country specific risks &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211; &lt;/font&gt;Investment primarily in equity and equity-related securities in the People&amp;#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Risks of investments in Russia &lt;/font&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#160;&lt;/font&gt;A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&amp;#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&amp;#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035586_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Principal Risks of Investing in the Fund&lt;/font&gt;&amp;#8221; please add the following risks:&lt;/font&gt;&lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;China and India country specific risks &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211; &lt;/font&gt;Investment primarily in equity and equity-related securities in the People&amp;#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Frontier market countries risk&lt;/font&gt; &amp;#8211; Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Risks of investments in Russia &lt;/font&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#160;&lt;/font&gt;A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&amp;#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&amp;#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000035590_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012S000037896_Member">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
  <cvst1:SupplementTextBlock contextRef="Duration_01May2011_30Apr2012">&lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Summary Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Supplement Dated September 10, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;To The Prospectus Dated April 30, 2012&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"&gt;Curian Variable Series Trust&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;For Curian Guidance &amp;#8211; Maximize Income Fund, Curian Guidance &amp;#8211; Balanced Income Fund, Curian Guidance &amp;#8211; Rising Income Fund, Curian Guidance &amp;#8211; Moderate Growth Fund, Curian Guidance &amp;#8211; Maximum Growth Fund, Curian Guidance &amp;#8211; Tactical Moderate Growth Fund, Curian Guidance &amp;#8211; Tactical Maximum Growth Fund, Curian Guidance &amp;#8211; Equity 100 Fund, Curian Guidance &amp;#8211; Fixed Income 100 Fund, Curian Guidance &amp;#8211; Institutional Alt 65 Fund, Curian Guidance &amp;#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &amp;#8211; Diversified Fund, Curian Dynamic Risk Advantage &amp;#8211; Aggressive Fund, Curian Dynamic Risk Advantage &amp;#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;counterparty and settlement risk&lt;/font&gt;&amp;#8221; in its entirety and replace it with the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;tr valign="top"&gt;&lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt;&lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt;&lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Principal Risks of Investing in the Fund&lt;/font&gt;&amp;#8221; please add the following risks:&lt;/font&gt;&lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;China and India country specific risks &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211; &lt;/font&gt;Investment primarily in equity and equity-related securities in the People&amp;#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Risks of investments in Russia &lt;/font&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#160;&lt;/font&gt;A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&amp;#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&amp;#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled &amp;#8220;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Principal Risks of Investing in the Fund&lt;/font&gt;&amp;#8221; please add the following risks:&lt;/font&gt;&lt;/div&gt;  &lt;div style="TEXT-INDENT: 0pt; DISPLAY: block"&gt;&lt;br/&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;China and India country specific risks &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211; &lt;/font&gt;Investment primarily in equity and equity-related securities in the People&amp;#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Counterparty and settlement risk&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt; &amp;#8211; &lt;/font&gt;Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Frontier market countries risk&lt;/font&gt; &amp;#8211; Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;  &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt; &lt;tr valign="top"&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 36pt"&gt; &lt;div style="TEXT-ALIGN: center"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: normal"&gt;&amp;#9679;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline"&gt;Risks of investments in Russia &lt;/font&gt;&lt;font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&amp;#160;&lt;/font&gt;A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&amp;#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&amp;#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvst1:SupplementTextBlock>
</xbrl>
